ArticleVeterinary medicine and science2025
Probiotic Viability and Bioactive Properties of Buffalo Yoghurt Produced Using High Cholesterol-Assimilating Probiotic Strains.
Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioactive Peptide-Enriched Requeson: A Functional Dairy Product From Whey Fermentation.Food science & nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThis study aimed to produce yoghurt with reduced cholesterol levels, enhanced antioxidant activity and angiotensin-converting enzyme (ACE) inhibitory activity while maintaining acceptable health properties, using buffalo milk and probiotic microorganisms.
methodBuffalo yoghurts were produced using three different probiotic strains, including Lactobacillus acidophilus, Lactiplantibacillus plantarum and Bifidobacterium lactis. ACE-inhibitor activities (%), antioxidant activities as DPPH (%), and cholesterol activities in HPLC of these yoghurts were determined during the 28-day storage period. In addition, probiotic microorganisms, total aerobic mesophilic bacteria and yeast mould were counted during storage.
resultsThe viability of probiotic microorganisms in buffalo yoghurts remained above 5 log CFU/g at the end of the storage period. Antioxidant activity ranged from 9.30% to 27.20%. Buffalo yoghurt is produced with Lpb. plantarum, which exhibited the highest viability (9.12 log CFU/g) and antioxidant activity values of 61.48%. Gastrointestinal digestion affected the antioxidant and ACE-inhibitor properties of the yoghurt samples. The highest ACE-inhibitory effect after gastric digestion on the 28th day was observed in yoghurt-produced Lpb. plantarum and B. lactis, with 24.30% and 25.14% values, respectively. Also, the ACE-inhibitory activity of the outer (OUT) phase for all yoghurt samples was higher than that of undigested samples. According to cholesterol peaks obtained in HPLC, the highest cholesterol assimilation was detected in yoghurt produced using Lpb. plantarum.
conclusionThe data obtained from the study may contribute to research on the potential of probiotic microorganisms with cholesterol-assimilation ability and probiotic food products produced using them to reduce cholesterol risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.